Impact of treatment with saxagliptin on glycaemic stability and ß-cell function in the SAVOR-TIMI 53 study.

Leibowitz, G; Cahn, A; Bhatt, D L; Hirshberg, B; Mosenzon, O; Wei, C; Jermendy, G; Sheu, W H-H; Sendon, J L; Im, K; Braunwald, E; Scirica, B M; Raz, I

Impact of treatment with saxagliptin on glycaemic stability and ß-cell function in the SAVOR-TIMI 53 study.

Leibowitz, G; Cahn, A; Bhatt, D L; Hirshberg, B; Mosenzon, O; Wei, C; Jermendy, G; Sheu, W H-H; Sendon, J L; Im, K; Braunwald, E; Scirica, B M; Raz, I.

Affiliation

Leibowitz G; The Diabetes Unit, Hadassah University Hospital, Jerusalem, Israel; The Endocrine Service, Hadassah University Hospital, Jerusalem, Israel.

Diabetes Obes Metab ; 17(5): 487-94, 2015 May.

Article in En | MEDLINE | ID: mdl-25656169

Subject(s)

Adamantane/analogs & derivatives; Blood Glucose/drug effects; Diabetes Mellitus, Type 2/drug therapy; Dipeptides/therapeutic use; Dipeptidyl-Peptidase IV Inhibitors/therapeutic use; Insulin-Secreting Cells/drug effects; Adamantane/therapeutic use; Aged; Diabetes Mellitus, Type 2/blood; Double-Blind Method; Fasting/blood; Female; Glycated Hemoglobin/drug effects; Glycated Hemoglobin/metabolism; Humans; Hypoglycemic Agents/therapeutic use; Insulin/therapeutic use; Insulin-Secreting Cells/metabolism; Male; Middle Aged; Prospective Studies

Key words

clinical trial; dipeptidyl peptidase-4 inhibitor; glycaemic control; type 2 diabetes; ß cell

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Blood Glucose / Adamantane / Diabetes Mellitus, Type 2 / Dipeptides / Insulin-Secreting Cells / Dipeptidyl-Peptidase IV Inhibitors Type of study: Clinical_trials / Observational_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Diabetes Obes Metab Year: 2015 Document type: Article

Fulltext

XML

PubMed Links

Search on Google